Eliot Forster - Sep 14, 2023 Form 3 Insider Report for Protalix BioTherapeutics, Inc. (PLX)

Role
Director
Signature
/s/ Eyal Rubin, POA
Stock symbol
PLX
Transactions as of
Sep 14, 2023
Transactions value $
$0
Form type
3
Date filed
9/15/2023, 04:45 PM
Previous filing
Mar 9, 2023

No securities are beneficially owned.